Mannose binding lectin level and polymorphism in patients on long-term peritoneal dialysis

Nephrology Dialysis Transplantation

Volumn 20, Issue 11, 2005, Pages 2489-2496

  Lam, Man Fai ^a   Leung, Joseph C K ^a   Tang, Colin C S ^a   Lo, Wai Kei ^a   Tse, Kai Chung ^a   Yip, Terrance P ^a   Lui, Sing Leung ^a   Chan, Tak Mao ^a   Lai, Kar Neng ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Gene mutation; Haemodialysis; Mannose binding lectin; Peritoneal dialysis; Peritonitis

Indexed keywords

MANNOSE BINDING LECTIN;

ADULT; AGED; ARTICLE; BACTERIAL PERITONITIS; BACTERIUM CARRIER; CODON; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; HEMODIALYSIS PATIENT; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; KIDNEY FAILURE; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PERITONEUM ADHESION; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR;

ADULT; ASCITIC FLUID; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXONS; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HUMANS; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; RISK FACTORS; UREMIA;

EID: 27644522825     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi089     Document Type: Article

References (20)

1. Golper TA, Brier ME, Bunke M et al. Risk factors for peritonitis in long-term peritoneal dialysis: The Network 9 peritonitis and catheter survival studies. Academic Subcommittee of the Steering Committee of the Network 9 Peritonitis and Catheter Survival Studies. Am J Kidney Dis 1996; 28: 428-436
2. Harwell CM, Newman LN, Cacho CP, Mulligan DC, Schulak JA, Friedlander MA. Abdominal catastrophe: Visceral injury as a cause of peritonitis in patients treated by peritoneal dialysis. Perit Dial Int; 17: 586-594
3. Fried L, Bernardini J, Piraino B. Iatrogenic peritonitis: The need for prophylaxis. Perit Dial Int 2000; 20: 343-345
4. Piraino B. Peritoneal infections. Adv Ren Replace Ther 2000; 7: 280-288
5. Tabona P, Mellor A, Summerfield JA. Mannose binding protein is involved in first-line host defence: Evidence from transgenic mice. Immunology 1995; 85: 153-159
6. Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, Turner MW. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 2000; 68: 688-693
7. Madsen HO, Garred P, Thiel S et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995; 155: 3013-3020
8. Summerfield JA, Ryder S, Sumiya M et al. Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet 1995; 345: 886-889
9. Yuen MF, Lau CS, Lau YL, Wong WM, Cheng CC, Lai CL. Mannose binding lectin gene mutations are associated with progression of liver disease in chronic hepatitis B infection. Hepatology 1999; 29: 1248-1251
10. Rector A, Lemey P, Laffut W et al. Mannan-binding lectin (MBL) gene polymorphisms in ulcerative colitis and Crohn's disease. Genes Immun 2001; 2: 323-328
11. Kiernan L, Kliger A, Gorban-Brennan N et al. Comparison of continuous ambulatory peritoneal dialysis-related infections with different 'Y-tubing' exchange systems. J Am Soc Nephrol 1995; 5: 1835-1838
12. Bernardini J, Piraino B, Holley J, Johnston JR, Lutes R. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am J Kidney Dis 1996; 27: 695-700
13. Lipscombe RJ, Beatty DW, Ganczakowski M et al. Mutations in the human mannose-binding protein gene: Frequencies in several population groups. Eur J Hum Genet 1996; 4: 13-19
14. Ip WK, Lau YL, Chan SY et al. Mannose-binding lectin and rheumatoid arthritis in southern Chinese. Arthritis Rheum 2000; 43: 1679-1687
15. Terai I, Kobayashi K, Fujita T, Hagiwara K. Human serum mannose binding protein (MBP): Development of an enzyme-linked immunosorbent assay (ELISA) and determination of levels in serum from 1085 normal Japanese and in some body fluids. Biochem Med Metab Biol 1993; 50: 111-119
16. Satomura A, Endo M, Ohi H et al. Significant elevations in serum mannose-binding lectin levels in patients with chronic renal failure. Nephron 2002; 92: 702-704
17. Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000; 58:1758-1764
18. Lo WK, Cheng SW, Lo CY, Li FK, Chan TM, Cheng IKP. Patient and technique survival in continuous ambulatory peritoneal dialysis (CAPD) with a basic three 2-liter daily exchanges: A 12-year single center experience in the pre-urea kinetics era. HK J Nephrol 1999; 1: 35-40
19. McGregor SJ, Brock JH, Briggs JD, Junor BJ. Relationship of IgG, C3 and transferrin with opsonising and bacteriostatic activity of peritoneal fluid from CAPD patients and the incidence of peritonitis. Nephrol Dial Transplant 1987; 2: 551-556
20. Anwar N, Hutchison AJ, Manos J, Uttley L, Brenchley P, Gokal R. Peritoneal dialysate IgG/C3 levels do not predict susceptibility to peritonitis. Perit Dial Int 1996; 16: 154-157